ABI
LLY icon

Adamant Biomedical Investments’s Eli Lilly LLY Stock Holding History

Adamant Biomedical Investments’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$5.52M Hold
80,000
– – 1.32% 24
2014
Q3 		$5.19M Buy
+80,000
New +$5.07M 1.29% 28

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Adamant Biomedical Investments's LLY Position: Q4 2014 in Review

Adamant Biomedical Investments held its Eli Lilly (LLY) position steady in Q4 2014 at 80,000 shares worth $5.52M. The position accounts for 1.32% of the portfolio, ranked #24.

Adamant Biomedical Investments first reported a position in LLY in Q3 2014 and has held it in 2 quarters since. 1,129 funds tracked by Wall St. Rank hold LLY as of Q4 2014.

  • Adamant Biomedical Investments held 80,000 shares of Eli Lilly worth $5.52M as of Q4 2014.
  • Adamant Biomedical Investments left its Eli Lilly share count unchanged in Q4 2014.
  • Eli Lilly made up 1.32% of Adamant Biomedical Investments's portfolio in Q4 2014, its #24 holding.
  • Adamant Biomedical Investments first reported a position in Eli Lilly in Q3 2014 and has held it in 2 quarters since.
  • 1,129 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.